Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial

Saved in:

Bibliographic Details
Published in	Journal of the American Academy of Dermatology Vol. 87; no. 6; pp. 1380 - 1383
Main Authors	Naik, Haley B., Pichard, Dominique C., Schwartz, Daniella M., O'Brien, Michelle, Masciocchi, Matthew, Thompson, Julie, Sen, H. Nida, Steinberg, Seth M., Mitchell, Sandra A., de Jesus, Adriana A., McCalmont, Timothy H., Dey, Amit, Rosenstein, Rachel K., Deng, Zuoming, Goldbach-Mansky, Raphaela, Mehta, Nehal N., Cowen, Edward W.
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.12.2022
Subjects	Dermatologic Agents - therapeutic use Humans Interleukin 1 Receptor Antagonist Protein - adverse effects Psoriasis - drug therapy Skin Diseases, Vesiculobullous - drug therapy
Online Access	Get full text
ISSN	0190-9622 1097-6787 1097-6787
DOI	10.1016/j.jaad.2022.07.065

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0190-9622 1097-6787 1097-6787
DOI:	10.1016/j.jaad.2022.07.065